Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoidosis.

Jennifer J Wu1, Karin Rashcovsky Schiff

  • 1Department of Family and Preventive Medicine, University of California, San Diego, School of Medicine, La Jolla, California 92103, USA. j1wu@ucsd.edu

American Family Physician
|August 5, 2004
PubMed
Summary

Sarcoidosis, a systemic granulomatous disease, presents with varied organ involvement. Current treatments like corticosteroids are standard but lack evidence for optimal use, necessitating further research into effective sarcoidosis management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Influencing Primary Care Physicians' Intent to Refer Patients With Hypertension to a Digital Remote Blood Pressure Monitoring Program: Mixed Methods Study.

Journal of medical Internet research·2025
Same author

Implementing change in health professions education: stakeholder analysis and coalition building.

Journal of veterinary medical education·2007
See all related articles

Area of Science:

  • Immunology
  • Pulmonology
  • Rheumatology

Background:

  • Sarcoidosis is a systemic granulomatous disease of unknown etiology.
  • It commonly affects young and middle-aged adults, presenting with diverse clinical manifestations including pulmonary, ocular, and skin lesions.
  • Multisystem involvement can affect the heart, liver, nervous system, and other organs.

Purpose of the Study:

  • To review the current understanding of sarcoidosis diagnosis, prognosis, and management.
  • To highlight the evidence gaps in optimal treatment strategies for sarcoidosis.
  • To discuss the role of various therapeutic agents and supportive care in managing sarcoidosis.

Main Methods:

  • Review of existing literature on sarcoidosis.
  • Analysis of diagnostic criteria, including clinicoradiologic findings and histology.
  • Evaluation of treatment modalities, including corticosteroids, cytotoxic agents, and transplantation.

Main Results:

  • Diagnosis relies on clinicoradiologic findings, histology (noncaseating epithelioid granulomas), and exclusion of other diseases.
  • Prognosis is influenced by onset, host factors, clinical course, and disease extent.
  • Corticosteroids are the primary treatment, but optimal use is undefined; other agents like methotrexate and antimalarials have specific roles, while transplantation is for end-stage disease.

Conclusions:

  • The optimal management of sarcoidosis remains undefined, with limited evidence for current therapeutic approaches.
  • Corticosteroids are the mainstay, but their initiation, dosage, and duration require further investigation.
  • Monitoring for drug toxicity and managing complications like osteoporosis are crucial aspects of patient care.

Related Experiment Videos